|
|
|
National Immunization Programme (NIP)
|
|

|
|
Routine Immunization
|
|
Goal & objectives
|
Achievements
|
NIP history
|
|
|
The National
Immunization Programme (at the time known as the
Expanded Programme on Immunization - EPI) was
initiated in 1979 in three districts with only two antigens (BCG and DPT) and
was rapidly expanded to include all 75 districts with all six recommended
antigens (BCG, DTP, OPV, and measles) by 1988. In 2003, with the support of
the GAVI Alliance, monovalent Hepatitis B (HepB) vaccine was introduced, which was later
administered as a single tetravalent (DPT-HepB)
injection. In 2009, vaccination against Haemophilus
influenzae type b was introduced through out the
nation in a phase wise manner starting in Far Western (FWDR) and Western
(WDR) Development Regions. Also in 2009, Japanese encephalitis (JE) vaccine
was introduced into the routine immunization programme
in 16 JE endemic districts following JE mass vaccination campaigns.
Routine
immunization Schedule for children and pregnant women
|
Vaccine
Disease(s) prevented
|
Number of Doses
|
Recommended Age
|
|
BCG
tuberculosis
|
1
|
At birth or on
first contact
|
|
OPV
Polio
|
3
|
6, 10, and 14
weeks of age
|
|
DPT-HepB-Hib
Diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b
|
3
|
6, 10, and 14
weeks of age
|
|
Measles
|
1
|
9 months of age
|
|
TT
tetanus
|
2
|
All Pregnant
women
Note – 5 doses
of TT vaccine during a woman’s reproductive life
|
|
JE
Japanese
encephalitis
|
1
|
12 to 23 months
|
All children
should receive the suggested number of doses of BCG, DPT-HepB-Hib,
OPV, and measles vaccines during their first year of life. Similarly, all
women of childbearing age should complete 5 doses of TT vaccine during their
reproductive life. JE vaccine is
available in the routine immunization programme
only in districts with high risk of Japanese encephalitis transmission. All
of the vaccines in the routine immunization schedule are provided free of
cost in all public health facilities in Nepal.
|
| Goal
The goal of NIP
is to reduce morbidity and mortality associated with vaccine preventable
diseases.
Objectives
1. Achieve and sustain 90% coverage of DPT3 by
2008 and all antigens in all district by 2010;
2. Maintain polio free status;
3. Sustain MNT elimination status;
4. Initiate measles elimination initiatives from
2010;
5. Expand vaccine preventable diseases (VPD)
surveillance;
6. Accelerate control of other VPD through
introduction of new vaccines;
7. Improve and sustain immunization quality;
8. Expand immunization service beyond infancy.
Source: cMYP
2007-2011, MoHP
Service delivery
Nepal is
geographically divided into five ecological regions which are Far-western,
Mid-western, Western, Central and Eastern Regions. These regions are further
divided into 75 administrative districts. In each district, there are
hospitals (at least one), primary health care centers (PHC), health posts
(HP) and sub health posts (SHP) through which health
care services are delivered. Immunization services are provided through the
fixed (health facilities) as well as out reach sessions. Hospitals, PHCs, HPs and SHPs provide immunization services through established
clinics. In addition there are 3 to 5 outreach
sessions conducted monthly in each VDC or Village Development Committee.
Village health workers are primarily responsible for providing immunization
services. Female community health volunteers (FCHVs)
are the key link between the community and service providers. Their role has
been crucial toward achieving and sustaining high immunization coverage
through routine or supplemental services.
Go to top é
|
| Achievements
Objective 1: Achieve and sustain 90%
coverage for all antigens
The coverage
status of immunization for all antigens in Nepal remains satisfactory. The
reported coverage status of the country is around 80% for all antigens. The
drop-out rate for all antigens is decreasing. However, the immunization
coverage is not uniform throughout and within the districts. Intensified
monitoring of VDC coverage (by categorizing the VDCs
as per their performance) has been implemented at district level since 2002
in order to promote universal coverage at all VDCs
for all antigens.
Trends in
immunization coverage among children 12-23 months

|
|
Objective 2: Maintain polio free status
In 1996, Nepal
initiated polio eradication efforts by holding the first Nepal National
Immunization Days (NIDs) in all 75 districts. Since
then, the polio eradication efforts have continued and expanded. Nepal
has achieved and maintained global certification-standard AFP surveillance
since 2001.
|
Indicators
|
2001
|
2002
|
2003
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
|
Non-polio AFP rate per 100,000 children less than 15 years
|
1.95
|
2.00
|
1.90
|
2.16
|
2.25
|
3.50
|
3.24
|
3.94
|
4.14
|
5.15
|
|
Stool adequacy
|
83%
|
87%
|
86%
|
84%
|
84%
|
86%
|
83%
|
88%
|
88%
|
89%
|
|
Polio cases
|
0
|
0
|
0
|
0
|
4
|
5
|
5
|
6
|
0
|
6
|
|
Polio compatible
|
0
|
1
|
1
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
Polio3 coverage, 1988 to 2010

Go to
top é
|
|
Objective 3:
Sustain MNT elimination status
In 2000, Nepal began
concerted efforts to meet the goal of maternal and neonatal tetanus
elimination (MNTE) with the initiation of 3-doses of tetanus toxoid (TT) supplemental immunization activities (SIAs). All 75 districts completed the SIAs
to achieve MNTE by the end of 2004.
In 2005, WHO
& UNICEF validated that Nepal
had eliminated neonatal tetanus (NT), i.e., achieved an NT incidence of less
than one case per 1,000 live births in every district of the country.
Results from the 2006 Nepal Demographic and Health Survey (NDHS) provided
further evidence of NT elimination. School-based immunizations for grade one
students in 12 districts and immunization of pregnant women with TT is
ongoing. Through VPD surveillance, eighteen neonatal tetanus cases were
investigated and confirmed in 2009.
NT cases and TT2+ coverage, 1998-2009

|
|
Objective 4:
Measles elimination initiatives
Measles was
endemic in Nepal
and was a major cause of child hood morbidity and mortality. However, the
burden of measles disease and its associated mortality has decreased sharply
after the introduction of measles vaccine through catch-up and follow-up
measles campaigns in 2004/05 and 2008/09.
Measles cases and MCV1 coverage, 1980-2009

The government of
Nepal
is committed to reduce the mortality and morbidity related to measles. The
commitment has been reflected in the “Comprehensive Immunization Multi Year
Plan of Action” (cMYPA) 2007-2011, which sets a
target to reduce measles mortality by 90% by 2009 compared to 2003 estimates,
to achieve at least 90% MCV1 coverage at national and district level by 2010
and to initiate measles elimination by 2010.
Go to top é
|
|
Objective 5
and 6: Accelerate, control and sustain of other vaccine preventable diseases
Other vaccine
preventable diseases for which vaccines are included in the routine
immunization schedule are hepatitis B, Haemophilus influenzae type b (Hib), and
Japanese encephalitis (JE).
Vaccinations for hepatitis B and Hib are
included along with diphtheria, pertussis and
tetanus in a pentavalent vaccine where protection
against all five diseases is provided in each injection of the three-dose
series. In Nepal,
the estimated annual incidence of Hib among
children less than five years of age is 5.4 cases per 100,000. However, low lumbar puncture rates and low
rates of Hib isolation from cerebral spinal fluid
(CSF) indicate that available data may underestimate the true disease burden.
According to WHO estimates, the Hib meningitis
incidence in Nepal
is approximately 19/100,000 among children under five years of age. Sentinel
sites for the surveillance of Hib diseases as well
as other types of invasive bacterial diseases are functional in selected
hospitals in Nepal.
JE was first
confirmed in Nepal in 1978
after an outbreak in the western part of the country (Rupendehi
district) along the border with India. Since then, JE infection
has been reported in humans throughout the terai
region, which borders India,
during and after the annual monsoon season from May to October. JE
vaccination has been included into routine immunization in the JE endemic
districts (where JE campaigns have been conducted). Surveillance for acute
encephalitis syndrome (clinical syndrome present for JE cases) is ongoing
through out the country.
WHO is providing
technical and financial support for burden of disease studies for other VPDs in order to support the Government of Nepal in its
decision making process to introduce other vaccinations in the routine
immunization schedule.
|
|
Objective 7:
Improve and sustain immunization quality
All immunizations provided during infancy
are WHO-prequalified.
Objective 8:
Expand immunization service beyond infancy
JE vaccine, which was introduced into the
routine immunization program in 16 districts in 2009, is the first vaccine to
be routinely administered for all children after the first year of life.
A demonstration project is ongoing in 12
districts where TT vaccine is provided to grade one students. It is likely that additional vaccines will
be added targeting toddlers or school aged children.
|
|
|
| NIP history
at a glance
Go to
top é
|
Year
|
Activity
|
|
1979
|
Started
immunization program with BCG and OPV in three districts.
|
|
1988
|
Nationwide
immunization program with BCG, OPV, DTP, Measles.
|
|
1996
|
First
nationwide polio immunization campaign.
|
|
1998
|
Polio
Eradication Nepal (PEN) was established with four surveillance field
offices.
Nepal
National Certification Committee was formed.
Surveillance
Medical Officers hired by WHO to support polio
eradication activities.
International
and national review for polio eradication initiatives
|
|
2000
|
Last
reported indigenous case of poliomyelitis in Nepal.
|
|
2001
|
Program
expands to 14 surveillance field offices (10 in 2005).
National
Expert Review Committee starts virological
classification of AFP cases.
AFP
surveillance achieves internationally accepted standards.
|
|
2002
|
National
Task Force for Laboratory Containment of wild poliovirus formed.
TT
campaign was initiated (2002-2004, for age 11 to 39 and 15 to 45 years)
|
|
2003
|
Measles
and tetanus surveillance integrated into AFP surveillance network.
National
Public Health Laboratory accredited by WHO as a
National Laboratory for Measles surveillance.
National
immunization injection safety policy
Hepatitis
B included in the routine immunization schedule.
|
|
2004
|
Surveillance
for acute encephalitis syndrome (AES) for Japanese encephalitis (JE)
integrated into AFP surveillance.
Nationwide
Measles catch up immunization campaign initiated (2004-2005, in three phases).
|
|
2005
|
Neonatal
tetanus elimination achieved.
Sentinel
surveillance for Haemophilus Influenzae
type b initiated.
Immunization
Officers hired to support routine immunization.
School
immunization was initiated with TT for student (grade 1, 2 and 3) in 8
districts
|
|
2006
|
Japanese
encephalitis catch up campaigns initiated in high risk districts.
International
and national AFP surveillance review.
|
|
2007
|
Measles
case-based surveillance initiated.
|
|
2008
|
Measles
follow up campaign integrated with OPV nationwide (in two phases).
Rubella
burden of disease studies initiated.
National
Committee for Immunization Practice Formed.
|
|
2009
|
Hib vaccine
included in the routine immunization schedule.
JE
vaccine included in the routine immunization schedule in 17 districts that
completed catch up campaigns.
EPI
coverage survey.
Sentinel
surveillance site for rotavirus initiated.
Sentinel
sites for Hib disease expanded to include
pneumococcal disease.
Initiated
pneumonia surveillance to support H5N1, H1N1 influenza through AFP
surveillance network.
Provided
technical support for cholera outbreak in Mid West Development Region.
|
|
2010
|
International
and national review of vaccine preventable diseases and EPI.
|
|
|
|
|
|
|
|